Ptcb Quiz: Dscsa Compliance
20 questions · exam conditions
0:00
Dscsa ComplianceQuestion 1 of 20

If a pharmacy receives a request from the FDA or an authorized trading partner for the transaction history of a specific drug, the pharmacy must provide this information:

within 2 business days.
within 10 business days.
within 30 calendar days.
at the next scheduled inspection.
← Back to quizzes

Ptcb Quiz

Ptcb Quiz: Dscsa Compliance

Practice Dscsa Compliance in Ptcb with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Dscsa Compliance, giving you a quick way to practice the rules, question types, and explanations that matter most for Ptcb.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

If a pharmacy receives a request from the FDA or an authorized trading partner for the transaction history of a specific drug, the pharmacy must provide this information:

  1. within 2 business days. (correct answer)
  2. within 10 business days.
  3. within 30 calendar days.
  4. at the next scheduled inspection.
Explanation: DSCSA requires dispensers to be able to provide the relevant transaction information, history, and statement for a specific product upon request from the FDA or a trading partner. The response must be prompt, with the established expectation being within 2 business days.

Question 2

A pharmacy technician is stocking an order and notices the expiration date on a bottle of medication is different from the expiration date listed on the Transaction Information document. This discrepancy means the product should be handled as a:

  1. recalled product.
  2. hazardous waste product.
  3. dispensing error.
  4. suspect product. (correct answer)
Explanation: Any inconsistency between the physical product and its transaction documentation is a red flag. A product with information that is inconsistent with its documentation is a reason to believe it may be suspect. The technician should quarantine the product and begin an investigation.

Question 3

Which entity in the drug supply chain is defined by the DSCSA as a 'dispenser'?

  1. A wholesale drug distributor.
  2. A pharmaceutical manufacturer.
  3. A retail pharmacy. (correct answer)
  4. A third-party logistics provider.
Explanation: Under the DSCSA, a 'dispenser' is a retail pharmacy, hospital pharmacy, or any other healthcare entity authorized by law to dispense or administer prescription drugs to patients. Wholesalers, manufacturers, and logistics providers are other types of trading partners with different roles and responsibilities.

Question 4

A patient returns an unopened, tamper-sealed box of medication for a refund. For the pharmacy to legally place this product back into its saleable inventory, the DSCSA requires that the pharmacy must be able to:

  1. verify the patient's identity with a photo ID.
  2. get a signed statement from the patient that the product was stored correctly.
  3. verify the product identifier and associate it with the original transaction documentation. (correct answer)
  4. ensure the return occurs within 24 hours of the original sale.
Explanation: For a returned product to be placed back into stock for resale, the pharmacy must be able to verify the product using its unique identifier and associate it with the original transaction information, history, and statement to ensure its legitimacy and proper chain of custody.

Question 5

While checking in a medication order, a pharmacy technician notices a bottle of amlodipine where the 2D barcode is scratched and unreadable. The lot number printed on the label also appears smeared.

What is the most appropriate first step for the technician to take according to DSCSA guidelines?

  1. Assume it is legitimate and place it into the pharmacy's stock.
  2. Destroy the product immediately to prevent its use.
  3. Quarantine the product and report it as 'suspect'. (correct answer)
  4. Ask the delivery driver to take the single bottle back.
Explanation: A product with an altered, damaged, or unreadable label or product identifier is considered a 'suspect product' under DSCSA. The first and most critical step is to physically separate (quarantine) the product to prevent it from being dispensed or mixed with legitimate stock while an investigation is conducted.

Question 6

A pharmacy completes an investigation and confirms that a batch of medication it received is illegitimate (counterfeit).

After quarantining the product, what is the pharmacy's next required action under DSCSA?

  1. Destroy the product and document the loss.
  2. Sell the product to a reverse distributor.
  3. Notify the FDA and immediate trading partners. (correct answer)
  4. Return the product to the pharmacy's active inventory.
Explanation: Upon determining a product is illegitimate, the pharmacy must promptly notify the FDA by submitting Form FDA 3911. They must also notify their immediate trading partners (both who they bought it from and who they may have sold it to) to prevent the illegitimate product from moving further in the supply chain.

Question 7

A pharmacy technician receives a tote from a wholesaler. The technician must verify that the DSCSA-required '3T' documentation is present before stocking the medications.

What do the '3Ts' of drug tracing under the DSCSA represent?

  1. Tracking, Tracing, and Testing
  2. Transaction Information, Transaction History, and Transaction Statement (correct answer)
  3. Temperature, Time, and Tamper-evidence
  4. Technician, Technologist, and Trainee
Explanation: The '3Ts' are the core components of the track-and-trace system. Transaction Information (TI) details the specific product in the transaction. Transaction History (TH) is a record of all prior transactions back to the manufacturer. Transaction Statement (TS) is an attestation from the seller confirming compliance.

Question 8

A pharmacy technician receives a tote from a wholesaler. The technician must verify that the DSCSA-required '3T' documentation is present before stocking the medications.

What do the '3Ts' of drug tracing under the DSCSA represent?

  1. Tracking, Tracing, and Testing
  2. Transaction Information, Transaction History, and Transaction Statement (correct answer)
  3. Temperature, Time, and Tamper-evidence
  4. Technician, Technologist, and Trainee
Explanation: The '3Ts' are the core components of the track-and-trace system. Transaction Information (TI) details the specific product in the transaction. Transaction History (TH) is a record of all prior transactions back to the manufacturer. Transaction Statement (TS) is an attestation from the seller confirming compliance.

Question 9

A pharmacy completes an investigation and confirms that a batch of medication it received is illegitimate (counterfeit).

After quarantining the product, what is the pharmacy's next required action under DSCSA?

  1. Destroy the product and document the loss.
  2. Sell the product to a reverse distributor.
  3. Notify the FDA and immediate trading partners. (correct answer)
  4. Return the product to the pharmacy's active inventory.
Explanation: Upon determining a product is illegitimate, the pharmacy must promptly notify the FDA by submitting Form FDA 3911. They must also notify their immediate trading partners (both who they bought it from and who they may have sold it to) to prevent the illegitimate product from moving further in the supply chain.

Question 10

A patient returns an unopened, tamper-sealed box of medication for a refund. For the pharmacy to legally place this product back into its saleable inventory, the DSCSA requires that the pharmacy must be able to:

  1. verify the patient's identity with a photo ID.
  2. get a signed statement from the patient that the product was stored correctly.
  3. verify the product identifier and associate it with the original transaction documentation. (correct answer)
  4. ensure the return occurs within 24 hours of the original sale.
Explanation: For a returned product to be placed back into stock for resale, the pharmacy must be able to verify the product using its unique identifier and associate it with the original transaction information, history, and statement to ensure its legitimacy and proper chain of custody.

Question 11

A pharmacy technician is stocking an order and notices the expiration date on a bottle of medication is different from the expiration date listed on the Transaction Information document. This discrepancy means the product should be handled as a:

  1. recalled product.
  2. hazardous waste product.
  3. dispensing error.
  4. suspect product. (correct answer)
Explanation: Any inconsistency between the physical product and its transaction documentation is a red flag. A product with information that is inconsistent with its documentation is a reason to believe it may be suspect. The technician should quarantine the product and begin an investigation.

Question 12

While checking in a medication order, a pharmacy technician notices a bottle of amlodipine where the 2D barcode is scratched and unreadable. The lot number printed on the label also appears smeared.

What is the most appropriate first step for the technician to take according to DSCSA guidelines?

  1. Assume it is legitimate and place it into the pharmacy's stock.
  2. Destroy the product immediately to prevent its use.
  3. Quarantine the product and report it as 'suspect'. (correct answer)
  4. Ask the delivery driver to take the single bottle back.
Explanation: A product with an altered, damaged, or unreadable label or product identifier is considered a 'suspect product' under DSCSA. The first and most critical step is to physically separate (quarantine) the product to prevent it from being dispensed or mixed with legitimate stock while an investigation is conducted.

Question 13

Which of the following products is generally EXEMPT from the serialization and tracing requirements of the DSCSA?

  1. A bottle of lisinopril tablets
  2. An injector pen of insulin glargine
  3. A vial of reconstituted amoxicillin suspension
  4. A container of sterile water for irrigation (correct answer)
Explanation: DSCSA has several exemptions. Products like certain intravenous solutions (e.g., for fluid replacement, irrigation, or sterile water), medical gases, and homeopathic drugs are exempt from the track-and-trace requirements. Common prescription drugs like lisinopril, insulin, and antibiotics are covered.

Question 14

What is the primary function of the unique serial number included in the DSCSA product identifier?

  1. To identify the drug's therapeutic category.
  2. To allow for tracking of the product at the individual package level. (correct answer)
  3. To indicate the wholesale acquisition cost of the drug.
  4. To link the drug package to a specific patient's prescription.
Explanation: The serial number is a unique alphanumeric code assigned to each individual saleable unit. Its purpose is to enable the tracking and tracing of a specific package as it moves through the supply chain, which is a core component of the DSCSA's security framework.

Question 15

In a 'drop shipment' scenario, a wholesaler directs the manufacturer to ship a product directly to the pharmacy. Who is responsible for providing the 3T documentation to the pharmacy?

  1. The manufacturer, because they physically shipped the product.
  2. The wholesaler, because they took ownership and sold the product to the pharmacy. (correct answer)
  3. The pharmacy, which must generate its own records for the transaction.
  4. The shipping carrier (e.g., FedEx or UPS).
Explanation: Even in a drop shipment, the transaction of ownership is from the manufacturer to the wholesaler, and then from the wholesaler to the pharmacy. Therefore, the wholesaler is the entity that sold the drug to the pharmacy and is responsible for providing the pharmacy with the required 3T documentation.

Question 16

After quarantining a suspect product, the pharmacy, in collaboration with trading partners, conducts an investigation. The primary goal of this investigation is to:

  1. determine if the product is illegitimate. (correct answer)
  2. negotiate a refund from the supplier.
  3. identify a new source for the medication.
  4. assign blame for the supply chain error.
Explanation: The entire purpose of quarantining and investigating a suspect product is to make a definitive determination: is the product authentic and safe, or is it illegitimate (e.g., counterfeit, diverted, stolen)? This determination dictates all subsequent actions, such as notifying the FDA and disposing of the product.

Question 17

What action is required if a pharmacy receives a product that has been the subject of a Class I recall and is also determined to be illegitimate under DSCSA?

  1. The product should be returned to the pharmacy's saleable stock.
  2. The product must be quarantined and handled according to both recall and DSCSA procedures. (correct answer)
  3. The recall procedure takes precedence, so DSCSA rules no longer apply.
  4. The product can be dispensed with a warning label to the patient.
Explanation: The product must be immediately quarantined. The pharmacy must then follow two parallel sets of procedures: the manufacturer's instructions for the recall AND the DSCSA requirements for illegitimate products, which includes notifying the FDA and trading partners. The two requirements are not mutually exclusive.

Question 18

A pharmacy transfers a bottle of a prescription medication to another pharmacy to help with a temporary shortage. Under DSCSA, this transfer requires:

  1. the creation and exchange of 3T documentation between the pharmacies. (correct answer)
  2. approval from the Drug Enforcement Administration (DEA).
  3. a new prescription from a physician.
  4. the transaction to be exempt from DSCSA as it is for a specific patient need.
Explanation: When a pharmacy transfers a drug to another pharmacy for any reason other than fulfilling a specific patient prescription, it is a change of ownership that requires the passing of 3T documentation. While there is an exemption for specific patient needs, a transfer for general stock shortage is a distribution that falls under DSCSA rules.

Question 19

A key security feature of the DSCSA is its requirement for an 'interoperable, electronic' system. What does 'interoperable' mean in this context?

  1. The system can be accessed using any web browser.
  2. The system allows different trading partners' software to communicate and exchange data seamlessly. (correct answer)
  3. The system can be operated by both pharmacists and pharmacy technicians.
  4. The system stores data in a way that is protected from cyberattacks.
Explanation: 'Interoperable' refers to the ability of different information systems, devices, and applications from various trading partners (manufacturers, wholesalers, pharmacies) to access, exchange, integrate, and cooperatively use data in a coordinated manner. This is essential for a seamless national track-and-trace system.

Question 20

The primary purpose of the Drug Supply Chain Security Act (DSCSA) is to:

  1. protect consumers from counterfeit, stolen, or contaminated medications. (correct answer)
  2. control the pricing of prescription medications sold in pharmacies.
  3. ensure the privacy of patient health information during dispensing.
  4. prevent the diversion of controlled substances for illicit use.
Explanation: The DSCSA was enacted to enhance the security of the U.S. drug supply chain. Its main goal is to protect patients from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful by implementing a national track-and-trace system.